Videos

Jolien
Robijns
UHasselt

Can light therapy prevent burns?

Many cancer patients undergo radiotherapy as a treatment. Unfortunately, due to this treatment they often suffer from painful burns. Jolien Robijns (Hasselt University International) tries to prevent these burns. How? By using laser light.
Yana
Dekempeneer
VUB

Cancer-free thanks to the camel?

Yana Dekempeneer is looking for a new, more effective method of treating breast cancer and she's putting her hope on camels... 
Elien
Derveaux
UHasselt

How lung cancer leaves useful traces in the blood

Every year about 8,000 people in Belgium develop lung cancer. These people may get the same diagnosis, but their bodies react differently. Elien Derveaux (Universiteit Hasselt) examines whether, on the basis of these differences, we can predict which treatment is most suitable for the patient.
Elien
De Thaye
UGent

Monitoring cancer in the blood

Waiting for results after a medical examination often causes stress and uncertainty, especially in cancer patients. That is why Elien De Thaye is working on a method to determine the effect of a chemo treatment on people with peritoneal cancer more quickly on the basis of a so-called marker in the blood.
Kristel
Paque
UGent
VUB

Are all those pills really needed as the end approaches?

Up to 91 pills a week. That's how many medicines people take at the end of their lives. Kristel Paque is investigating whether all these pills are really necessary.
Ruben
Van Paemel
FWO
UGent

Liquid biopsies in cancer diagnosis

Did you know that 1 in 100 people who develop cancer are under 18 years of age? In order to diagnose cancer, a surgical biopsy is often required. But Ruben Van Paemel and his colleagues want to change this. They want to detect cancer in children by taking a simple blood sample.
Celine
Everaert
FWO
UGent

Using computing power to fight cancer

Did you know that cancer researchers draw inspiration from applications such as Amazon, Facebook and even Tinder? Armed with a supercomputer, Celine Everaert, like these applications, processes large amounts of data. Not to sell books or to help people get on a date, but to offer cancer patients personalised treatments.
Ovia Margaret
Thirukkumaran
FWO
KU Leuven

HER2 breast cancer: comprehend to conquer it!

Did you know that breast cancer is the second most common cancer for women, affecting 1.7 million women worldwide? In her research Ovia Margaret Thirukkumaran is trying to decipher how cancer cells communicate and develop resistance against drugs in so called HER 2 breast cancer, a very aggressive form of breast cancer.
Jan-Pieter
Ploem
UHasselt

Flatworms help track down carcinogens!

Every year, many mice are sacrificed for science. These animals are used, among other things, to test whether certain substances are carcinogenic. Jan-Pieter Ploem is working on a new test method that uses flatworms, that will hopefully help save a lot of mice.
Hanne
Massonet
KU Leuven
UAntwerpen

Chronic swallowing problems after head and neck cancer

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.
Wiktoria
Wojtaczka
KU Leuven

Is the cure for cancer stuck in a jar?

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar
Sara
Verbandt
KU Leuven

Making immunotherapy stand up against colon cancer

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.